Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Garcia-Sosa, A.T.; Sild, S.; Maran, U.
    Design of multi-binding-site inhibitors, ligand efficiency, and consensus screening of avian influenza H5N1 wild-type neuraminidase and of the oseltamivir-resistant H274Y variant (2008), J. Chem. Inf. Model., 48, 2074-2080.
    View publication on PubMed

Application

EC Number Application Comment Organism
3.2.1.18 analysis virtual screening method for inhibitors based on consensus scoring and ligand efficiency indices, which allows the combination of pharmacodynamic and pharmacokinetic properties into unique measures influenza A virus

Protein Variants

EC Number Protein Variants Comment Organism
3.2.1.18 H274Y mutant resistant to oseltamivir, used for design of multi-binding-site inhibitors influenza A virus

Inhibitors

EC Number Inhibitors Comment Organism Structure
3.2.1.18 2-deoxy-2,3-dehydro-N-acetylneuraminic acid
-
influenza A virus
3.2.1.18 additional information construction of homologous and heterologous dimers and trimers and trimers of inhibitors such as oseltamivir(R)-CH2-(R)oseltamivir, oseltamivir(R)-O-zanamivir, oseltamivir(R)-CH2-2-deoxy-2,3-dehydro-N-acetylneuraminic acid and calculation of molecular properties and ligand efficiency values influenza A virus
3.2.1.18 oseltamivir
-
influenza A virus
3.2.1.18 peramivir
-
influenza A virus
3.2.1.18 zanamivir
-
influenza A virus

Organism

EC Number Organism UniProt Comment Textmining
3.2.1.18 influenza A virus
-
avain virus type H5N1
-